3-HYDROXY-3-METHYLGLUTARYL - COENZYME-A REDUCTASE INHIBITORS IN THE TREATMENT OF HYPERCHOLESTEROLEMIA

被引:145
作者
HOEG, JM
BREWER, HB
机构
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 1987年 / 258卷 / 24期
关键词
D O I
10.1001/jama.258.24.3532
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:3532 / 3536
页数:5
相关论文
共 42 条
[1]   MEVINOLIN - A HIGHLY POTENT COMPETITIVE INHIBITOR OF HYDROXYMETHYLGLUTARYL-COENZYME-A REDUCTASE AND A CHOLESTEROL-LOWERING AGENT [J].
ALBERTS, AW ;
CHEN, J ;
KURON, G ;
HUNT, V ;
HUFF, J ;
HOFFMAN, C ;
ROTHROCK, J ;
LOPEZ, M ;
JOSHUA, H ;
HARRIS, E ;
PATCHETT, A ;
MONAGHAN, R ;
CURRIE, S ;
STAPLEY, E ;
ALBERSSCHONBERG, G ;
HENSENS, O ;
HIRSHFIELD, J ;
HOOGSTEEN, K ;
LIESCH, J ;
SPRINGER, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1980, 77 (07) :3957-3961
[2]  
ANCHOR RWP, 1961, MAYO CLIN P, V36, P217
[3]  
[Anonymous], 1984, JAMA-J AM MED ASSOC, V251, P251
[4]  
AVIGAN J, 1960, J BIOL CHEM, V235, P3123
[5]   LOWERING PLASMA-CHOLESTEROL BY RAISING LDL RECEPTORS [J].
BROWN, MS ;
GOLDSTEIN, JL .
NEW ENGLAND JOURNAL OF MEDICINE, 1981, 305 (09) :515-517
[6]   15 YEAR MORTALITY IN CORONARY DRUG PROJECT PATIENTS - LONG-TERM BENEFIT WITH NIACIN [J].
CANNER, PL ;
BERGE, KG ;
WENGER, NK ;
STAMLER, J ;
FRIEDMAN, L ;
PRINEAS, RJ ;
FRIEDEWALD, W .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1986, 8 (06) :1245-1255
[7]   A NOVEL MODE OF INHIBITION OF CHOLESTEROL BIOSYNTHESIS [J].
DVORNIK, D ;
DUBUC, J ;
GAUDRY, R ;
KRAML, M ;
GIVNER, M .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1963, 85 (20) :3309-+
[8]   PRELIMINARY-REPORT - TREATMENT OF TYPE-3 HYPERLIPOPROTEINEMIA WITH MEVINOLIN [J].
EAST, CA ;
GRUNDY, SM ;
BILHEIMER, DW .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1986, 35 (02) :97-98
[9]   COMPETITIVE INHIBITION OF 3-HYDROXY-3-METHYLGLUTARYL COENZYME A REDUCTASE BY ML-236A AND ML-236B FUNGAL METABOLITES, HAVING HYPOCHOLESTEROLEMIC ACTIVITY [J].
ENDO, A ;
KURODA, M ;
TANZAWA, K .
FEBS LETTERS, 1976, 72 (02) :323-326
[10]   TESTICULAR FUNCTION IN TYPE-II HYPERLIPOPROTEINEMIC PATIENTS TREATED WITH LOVASTATIN (MEVINOLIN) OR NEOMYCIN [J].
FARNSWORTH, WH ;
HOEG, JM ;
MAHER, M ;
BRITTAIN, EH ;
SHERINS, RJ ;
BREWER, HB .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1987, 65 (03) :546-550